Compare Dentsply Sirona, Inc. with Similar Stocks
Dashboard
1
Poor Management Efficiency with a low ROCE of 6.38%
- The company has been able to generate a Return on Capital Employed (avg) of 6.38% signifying low profitability per unit of total capital (equity and debt)
2
With a fall in Operating Profit of -6.42%, the company declared Very Negative results in Mar 26
3
Risky -
4
Consistent Underperformance against the benchmark over the last 3 years
Stock DNA
Pharmaceuticals & Biotechnology
USD 2,818 Million (Small Cap)
105.00
NA
4.52%
1.53
2.00%
2.10
Revenue and Profits:
Net Sales:
880 Million
(Quarterly Results - Mar 2026)
Net Profit:
-10 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-8.24%
0%
-8.24%
6 Months
-6.24%
0%
-6.24%
1 Year
-32.74%
0%
-32.74%
2 Years
-58.86%
0%
-58.86%
3 Years
-72.63%
0%
-72.63%
4 Years
-71.38%
0%
-71.38%
5 Years
-83.5%
0%
-83.5%
Dentsply Sirona, Inc. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
1.95%
EBIT Growth (5y)
-1.89%
EBIT to Interest (avg)
5.20
Debt to EBITDA (avg)
2.74
Net Debt to Equity (avg)
0.96
Sales to Capital Employed (avg)
0.83
Tax Ratio
1.63%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
100.00%
ROCE (avg)
6.38%
ROE (avg)
7.23%
Valuation key factors
Factor
Value
P/E Ratio
105
Industry P/E
Price to Book Value
2.10
EV to EBIT
19.24
EV to EBITDA
8.04
EV to Capital Employed
1.44
EV to Sales
1.32
PEG Ratio
NA
Dividend Yield
4.52%
ROCE (Latest)
7.47%
ROE (Latest)
2.00%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Sideways
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bearish
Mildly Bullish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
Shareholding Snapshot : Mar 2026
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 103 Schemes (73.1%)
Foreign Institutions
Held by 189 Foreign Institutions (19.25%)
Strategic Entities with highest holding
Highest Public shareholder
Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ
Mar'26
Dec'25
Change(%)
Net Sales
880.00
961.00
-8.43%
Operating Profit (PBDIT) excl Other Income
111.00
112.00
-0.89%
Interest
23.00
21.00
9.52%
Exceptional Items
-42.00
-143.00
70.63%
Consolidate Net Profit
-10.00
-145.00
93.10%
Operating Profit Margin (Excl OI)
36.40%
20.80%
1.56%
USD in Million.
Net Sales
QoQ Growth in quarter ended Mar 2026 is -8.43% vs 6.31% in Dec 2025
Consolidated Net Profit
QoQ Growth in quarter ended Mar 2026 is 93.10% vs 66.12% in Dec 2025
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
3,680.00
3,793.00
-2.98%
Operating Profit (PBDIT) excl Other Income
605.00
579.00
4.49%
Interest
82.00
55.00
49.09%
Exceptional Items
-645.00
-1,089.00
40.77%
Consolidate Net Profit
-598.00
-910.00
34.29%
Operating Profit Margin (Excl OI)
68.80%
60.60%
0.82%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is -2.98% vs -4.34% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is 34.29% vs -589.39% in Dec 2024
About Dentsply Sirona, Inc. 
Dentsply Sirona, Inc.
Pharmaceuticals & Biotechnology
DENTSPLY SIRONA Inc. is a manufacturer of professional dental products and technologies. The Company develops, manufactures and markets solutions, including dental equipment and dental consumable products. The Company operates in two operating segments: Technologies & Equipment, and Consumables. The Technologies & Equipment segment is engaged in designing, manufacturing, sales and distribution of the Company's Dental Technology and Equipment Products and Healthcare Consumable Products. Its products include dental implants, CAD/CAM systems, orthodontic clear aligner products, imaging systems, treatment centers, instruments, as well as consumable medical device products. The Consumables segment is engaged in designing, manufacturing, sales and distribution of the Company's Dental Consumable Products, which include preventive, restorative, endodontic and dental laboratory products. It also offers treatment planning and a clear aligner solution delivered directly to a consumer's home.
Company Coordinates 
Company Details
13320 Ballantyne Corporate Pl , CHARLOTTE NC : 28277-3607
Registrar Details






